These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25885821)

  • 1. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.
    Parham GP; Mwanahamuntu MH; Kapambwe S; Muwonge R; Bateman AC; Blevins M; Chibwesha CJ; Pfaendler KS; Mudenda V; Shibemba AL; Chisele S; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Chi BH; Stringer JS; Sankaranarayanan R; Sahasrabuddhe VV
    PLoS One; 2015; 10(4):e0122169. PubMed ID: 25885821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.
    Bateman AC; Katundu K; Mwanahamuntu MH; Kapambwe S; Sahasrabuddhe VV; Hicks ML; Chi BH; Stringer JS; Parham GP; Chibwesha CJ
    BMC Cancer; 2015 Jul; 15():541. PubMed ID: 26205980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.
    Pfaendler KS; Mwanahamuntu MH; Sahasrabuddhe VV; Mudenda V; Stringer JS; Parham GP
    Gynecol Oncol; 2008 Sep; 110(3):402-7. PubMed ID: 18556050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
    PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana.
    Ramogola-Masire D; de Klerk R; Monare B; Ratshaa B; Friedman HM; Zetola NM
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):308-13. PubMed ID: 22134146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
    Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
    JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India.
    Anderson JR; Yogeshkumar S; Lu E; Yenokyan G; Thaler K; Mensa M; Chikaraddi S; Lokare L; Gudadinni MR; Antartani R; Donimath K; Patil B; Bidri S; Goudar SS; Derman R; Dalal A;
    BJOG; 2023 Nov; 130 Suppl 3(Suppl 3):158-167. PubMed ID: 37932903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia.
    Hu L; Mwanahamuntu MH; Sahasrabuddhe VV; Barrett C; Horning MP; Shah I; Laverriere Z; Banik D; Ji Y; Shibemba AL; Chisele S; Munalula MK; Kaunga F; Musonda F; Malyangu E; Hariharan KM; Parham GP
    Cancer Med; 2024 Jun; 13(11):e7355. PubMed ID: 38872398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
    Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
    AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness.
    Parham GP; Mwanahamuntu MH; Sahasrabuddhe VV; Westfall AO; King KE; Chibwesha C; Pfaendler KS; Mkumba G; Mudenda V; Kapambwe S; Vermund SH; Hicks ML; Stringer JS; Chi BH
    HIV Ther; 2010; 4(6):703-722. PubMed ID: 25419240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries.
    Forhan SE; Godfrey CC; Watts DH; Langley CL
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S350-6. PubMed ID: 25768874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
    Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
    J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
    Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
    Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
    Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
    BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
    Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
    BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province.
    Moon TD; Silva-Matos C; Cordoso A; Baptista AJ; Sidat M; Vermund SH
    J Int AIDS Soc; 2012 Jun; 15(2):17406. PubMed ID: 22713260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
    Pfaff C; Singano V; Akello H; Amberbir A; Berman J; Kwekwesa A; Matengeni A; Banda V; Msonko J; Speight C; Kabeya BM; van Oosterhout JJ
    Malawi Med J; 2018 Sep; 30(3):211-214. PubMed ID: 30627358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that Affected Women Undergoing Cryotherapy Following Cancer Screening with Visual Inspection of the Cervix Using Acetic Acid Method.
    Napitupulu D; Puspitaningtyas H; Mualim K; Kusumanto A; Lazuardi L; Hutajulu SH
    Asian Pac J Cancer Prev; 2020 May; 21(5):1423-1429. PubMed ID: 32458651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
    Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
    Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas].
    Zhang YZ; Ma JF; Zhao FH; Xiang XE; Ma ZH; Shi YT; Hu SY; Qiao YL
    Chin J Cancer; 2010 Jan; 29(1):4-8. PubMed ID: 20038302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.